Symptoms & Lifespan Journey: What to Expect
At a Glance
15q13.3 microdeletion syndrome affects development across the lifespan. Childhood symptoms often include low muscle tone, developmental delays, and absence seizures. In adolescence and adulthood, there is an increased risk for psychiatric conditions, making proactive medical monitoring essential.
Knowing what to expect can help you move from a state of uncertainty to a state of readiness. While 15q13.3 microdeletion syndrome affects everyone differently, there are common “themes” that tend to appear at different stages of life.
The Childhood Years: Building a Foundation
In early childhood, the focus is often on supporting physical and cognitive development. Most children with this syndrome have very few dysmorphic features (physical differences in appearance), meaning they generally look like other children in their family [1][2].
Movement and Development
Many infants and young children experience hypotonia, or low muscle tone [1]. This may make them feel a bit “floppy” when held and can lead to delays in reaching milestones like sitting up, crawling, or walking. While waiting for official physical therapy referrals, you can safely encourage movement at home with supervised and modified “tummy time.” Early physical and occupational therapy are often very effective in helping children gain strength and coordination [3].
Learning and Behavior
Developmental delays and intellectual disability (ID) can range from very mild to moderate [1]. Many children also show signs of Autism Spectrum Disorder (ASD) or ADHD [3]. Early intervention—such as speech therapy and specialized educational support—is the cornerstone of management during these years.
“Staring Spells”: Childhood Absence Seizures
One of the most common medical symptoms in 15q13.3 microdeletion is a specific type of epilepsy called absence seizures [4].
- What they look like: These are often called “staring spells.” Your child may suddenly stop what they are doing, stare into space for a few seconds, and then resume their activity as if nothing happened.
- What to do: If you suspect a staring spell, try to record it on your smartphone. Video evidence is incredibly helpful for the pediatric neurologist.
- Management and Safety: These seizures require careful medical management. It is completely normal if it takes trying a few different medications to find the one that works best [4]. Crucially, while medications are being adjusted, unmedicated staring spells pose a safety risk. You must exercise caution and supervise your child closely during activities like swimming, bathing, bike riding, or crossing the street.
Nutrition and Weight
Some children with this deletion, especially those missing the CHRNA7 gene, may have an increased risk for rapid weight gain or obesity [5]. Establishing healthy routines and clear boundaries around food early on can help manage this risk.
Adolescence and Adulthood: Navigating New Risks
As children move into their teenage years and beyond, the clinical focus often shifts from physical milestones to mental health and psychiatric well-being.
Neuropsychiatric Risks
Research indicates that individuals with a 15q13.3 microdeletion have an increased risk (approximately 10 times higher than the general population) for developing schizophrenia or other forms of psychosis in late adolescence or early adulthood [6].
Psychosis is a medical term for when a person has trouble distinguishing what is real from what is not. While this can be a scary prospect for parents, it is important to contextualize this risk:
- Understanding the Numbers: The general population risk for schizophrenia is about 1%. A 10-times higher risk means the risk is around 10%. This also means there is a 90% chance your child will never develop it. Because of incomplete penetrance, many adults with this deletion never develop these conditions [7].
- Modifiable Triggers: High levels of psychological stress and the use of illicit substances (especially heavy cannabis use during adolescence) are known environmental triggers for psychosis in genetically vulnerable individuals [8]. Educating your teen about these specific risks is a proactive step you can take.
- Anticipatory Guidance: Knowing the risk allows for “anticipatory guidance.” This means you and your child’s doctors can watch for early signs (like social withdrawal or unusual changes in thinking) and intervene with therapy or medication much sooner, which significantly improves long-term outcomes [3][9].
By staying observant and maintaining a strong relationship with a neurology or psychiatry team, you can provide the support your child needs as they transition into adulthood.
Common questions in this guide
What are the early childhood signs of 15q13.3 microdeletion syndrome?
What do seizures look like in children with a 15q13.3 microdeletion?
Does 15q13.3 microdeletion syndrome cause weight gain?
What is the risk of schizophrenia for someone with a 15q13.3 microdeletion?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my child show signs of absence seizures that we might be missing, and should I try to video record any suspicious staring spells?
- 2.How often should we have our child's growth and weight monitored specifically for obesity risks?
- 3.Can you help us establish a baseline neuropsychological evaluation now to track cognitive changes as they grow?
- 4.What are the early warning signs of psychiatric changes in adolescence we should be watching for?
- 5.Are there specific behavioral therapies that work best for the learning and developmental differences often seen with this deletion?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Atypical Prader-Willi and 15q13.3 Microdeletion Syndromes in a Patient with an Unbalanced Translocation.
Colovati MES, Grossi BM, Nunes GD, et al.
Cytogenetic and genome research 2019; (158(4)):192-198 doi:10.1159/000501753.
PMID: 31394532 - 2
Prenatal diagnosis of 15q13.3 deletion and duplication syndrome: what do we tell the prospective parents?
Luo X, Liu H, Chen X, et al.
Archives of gynecology and obstetrics 2025; (312(6)):1991-2000 doi:10.1007/s00404-025-08150-z.
PMID: 41123664 - 3
The complex behavioral phenotype of 15q13.3 microdeletion syndrome.
Ziats MN, Goin-Kochel RP, Berry LN, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2016; (18(11)):1111-1118 doi:10.1038/gim.2016.9.
PMID: 26963284 - 4
The spectrum of epilepsy in children with 15q13.3 microdeletion syndrome.
Whitney R, Nair A, McCready E, et al.
Seizure 2021; (92()):221-229 doi:10.1016/j.seizure.2021.09.016.
PMID: 34601452 - 5
Rapid-Onset Obesity Due to Impulsive Food-Seeking Behavior in a Puerto Rican Child With CHRNA7 15q13.3 Microdeletion.
Jiménez BL, Carlo S, De Jesús Rojas W
Cureus 2021; (13(3)):e14012 doi:10.7759/cureus.14012.
PMID: 33884253 - 6
Electrophysiological evidence for defective fast-spiking GABAergic neurones in a schizophrenia model.
Nakazawa K
Acta physiologica (Oxford, England) 2017; (220(1)):14-15 doi:10.1111/apha.12817.
PMID: 27987262 - 7
Genetic counseling of prenatally detected familial 15q13.2q13.3 microdeletion encompassing CHRNA7 and OTUD7A with asymptomatic carriers in the family.
Chen CP, Wu FT, Pan YT, et al.
Taiwanese journal of obstetrics & gynecology 2025; (64(2)):361-363 doi:10.1016/j.tjog.2024.12.015.
PMID: 40049827 - 8
Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.
Giovanoli S, Werge TM, Mortensen PB, et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2019; (44(4)):703-710 doi:10.1038/s41386-018-0189-3.
PMID: 30188511 - 9
Focal refractory epilepsy associated to 15q13.3 microduplication.
García Gómez E, San-Juan D, Romero Valencia J, Ortega-Arenas CJ
BMJ case reports 2025; (18(3)) doi:10.1136/bcr-2024-264671.
PMID: 40032575
This page provides an overview of 15q13.3 microdeletion syndrome symptoms for educational purposes. Always consult your child's pediatrician, neurologist, or psychiatrist for personalized medical advice and monitoring.
Get notified when new evidence is published on 15q13.3 microdeletion syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.